Exploration Capital, LLC 4

4 · Fresh Tracks Therapeutics, Inc. · Filed May 20, 2024

Insider Transaction Report

Form 4
Period: 2024-05-16
Transactions
  • Purchase

    Common Stock

    2024-05-20$0.91/sh+797$7251,300,589 total
  • Purchase

    Common Stock

    2024-05-16$0.92/sh+73,768$67,8671,299,792 total
Holdings
  • Common Stock

    47,000
Footnotes (3)
  • [F1]Exploration Capital, LLC ("X-Cap") is the investment manager of Exploration Capital Fund, LP (the "Partnership") and as a result may be deemed to be the beneficial owner of all the securities held by the Partnership. Exploration Capital General Partner, LLC (the "GP") is the general partner of the Partnership and as a result may be deemed to be the beneficial owner of all the securities held by the Partnership.
  • [F2]Stephen L. Gustin is the Managing Partner of X-Cap and as a result may be deemed to be the beneficial owner of all the securities held by the Partnership. Mr. Gustin disclaims beneficial ownership of the reported securities held by the Partnership except to the extent of his pecuniary interest.
  • [F3]These shares are directly owned by Stephen L. Gustin.

Documents

1 file
  • 4
    marketforms-65981.xmlPrimary

    PRIMARY DOCUMENT